A citation-based method for searching scientific literature

Fuyong Du, Simon A Hinke, Cassandre Cavanaugh, David Polidori, Nathanial Wallace, Thomas Kirchner, Matthew Jennis, Wensheng Lang, Gee-Hong Kuo, Micheal D Gaul, James Lenhard, Keith Demarest, Nadim J Ajami, Yin Liang, Pamela J Hornby. J. Pharmacol. Exp. Ther. 2018
Times Cited: 5







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity.
Amandine Everard, Clara Belzer, Lucie Geurts, Janneke P Ouwerkerk, Céline Druart, Laure B Bindels, Yves Guiot, Muriel Derrien, Giulio G Muccioli, Nathalie M Delzenne,[...]. Proc. Natl. Acad. Sci. U.S.A. 2013
40

Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.
Patrice D Cani, Audrey M Neyrinck, Nicole Maton, Nathalie M Delzenne. Obes. Res. 2005
196
40

Gut metagenome in European women with normal, impaired and diabetic glucose control.
Fredrik H Karlsson, Valentina Tremaroli, Intawat Nookaew, Göran Bergström, Carl Johan Behre, Björn Fagerberg, Jens Nielsen, Fredrik Bäckhed. Nature 2013
40

Metabolic endotoxemia initiates obesity and insulin resistance.
Patrice D Cani, Jacques Amar, Miguel Angel Iglesias, Marjorie Poggi, Claude Knauf, Delphine Bastelica, Audrey M Neyrinck, Francesca Fava, Kieran M Tuohy, Chantal Chabo,[...]. Diabetes 2007
40

A core gut microbiome in obese and lean twins.
Peter J Turnbaugh, Micah Hamady, Tanya Yatsunenko, Brandi L Cantarel, Alexis Duncan, Ruth E Ley, Mitchell L Sogin, William J Jones, Bruce A Roe, Jason P Affourtit,[...]. Nature 2009
40

SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice.
Dustin M Lee, Micah L Battson, Dillon K Jarrell, Shuofei Hou, Kayl E Ecton, Tiffany L Weir, Christopher L Gentile. Cardiovasc Diabetol 2018
40
40

A metagenome-wide association study of gut microbiota in type 2 diabetes.
Junjie Qin, Yingrui Li, Zhiming Cai, Shenghui Li, Jianfeng Zhu, Fan Zhang, Suisha Liang, Wenwei Zhang, Yuanlin Guan, Dongqian Shen,[...]. Nature 2012
40


Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity.
Alice P Liou, Melissa Paziuk, Jesus-Mario Luevano, Sriram Machineni, Peter J Turnbaugh, Lee M Kaplan. Sci Transl Med 2013
494
40

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice.
Amandine Everard, Vladimir Lazarevic, Muriel Derrien, Myriam Girard, Giulio G Muccioli, Audrey M Neyrinck, Sam Possemiers, Ann Van Holle, Patrice François, Willem M de Vos,[...]. Diabetes 2011
460
40

The environment within: how gut microbiota may influence metabolism and body composition.
A Vrieze, F Holleman, E G Zoetendal, W M de Vos, J B L Hoekstra, M Nieuwdorp. Diabetologia 2010
139
40

Human gut microbiota in obesity and after gastric bypass.
Husen Zhang, John K DiBaise, Andrea Zuccolo, Dave Kudrna, Michele Braidotti, Yeisoo Yu, Prathap Parameswaran, Michael D Crowell, Rod Wing, Bruce E Rittmann,[...]. Proc. Natl. Acad. Sci. U.S.A. 2009
958
40

Human gut microbiota changes reveal the progression of glucose intolerance.
Xiuying Zhang, Dongqian Shen, Zhiwei Fang, Zhuye Jie, Xinmin Qiu, Chunfang Zhang, Yingli Chen, Linong Ji. PLoS ONE 2013
272
40

Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models.
E F Murphy, P D Cotter, S Healy, T M Marques, O O'Sullivan, F Fouhy, S F Clarke, P W O'Toole, E M Quigley, C Stanton,[...]. Gut 2010
415
40

Bioavailability of phloretin and phloridzin in rats.
V Crespy, O Aprikian, C Morand, C Besson, C Manach, C Demigné, C Rémésy. J. Nutr. 2001
69
40

Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.
Valentin Gorboulev, Annette Schürmann, Volker Vallon, Helmut Kipp, Alexander Jaschke, Dirk Klessen, Alexandra Friedrich, Stephan Scherneck, Timo Rieg, Robyn Cunard,[...]. Diabetes 2012
332
40

Biology of human sodium glucose transporters.
Ernest M Wright, Donald D F Loo, Bruce A Hirayama. Physiol. Rev. 2011
573
40

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N. Engl. J. Med. 2015
40

Metformin--mode of action and clinical implications for diabetes and cancer.
Ida Pernicova, Márta Korbonits. Nat Rev Endocrinol 2014
456
20

Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis.
Tsung-Ru Wu, Chuan-Sheng Lin, Chih-Jung Chang, Tzu-Lung Lin, Jan Martel, Yun-Fei Ko, David M Ojcius, Chia-Chen Lu, John D Young, Hsin-Chih Lai. Gut 2019
66
20

Voglibose administration regulates body weight and energy intake in high fat-induced obese mice.
Hyun Ju Do, Taeon Jin, Ji Hyung Chung, Ji Won Hwang, Min-Jeong Shin. Biochem. Biophys. Res. Commun. 2014
7
20

Cellular and molecular mechanisms of metformin: an overview.
Benoit Viollet, Bruno Guigas, Nieves Sanz Garcia, Jocelyne Leclerc, Marc Foretz, Fabrizio Andreelli. Clin. Sci. 2012
747
20

Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?
Yoshihiko Suzuki, Motoaki Sano, Kentaro Hayashida, Ikuroh Ohsawa, Shigeo Ohta, Keiichi Fukuda. FEBS Lett. 2009
45
20

Effect of metformin on metabolic improvement and gut microbiota.
Heetae Lee, GwangPyo Ko. Appl. Environ. Microbiol. 2014
141
20

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
Tina Vilsbøll, Mikkel Christensen, Anders E Junker, Filip K Knop, Lise Lotte Gluud. BMJ 2012
414
20

Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis.
Erica L M Vieira, Alda J Leonel, Alexandre P Sad, Nathália R M Beltrão, Thaís F Costa, Talita M R Ferreira, Ana C Gomes-Santos, Ana M C Faria, Maria C G Peluzio, Denise C Cara,[...]. J. Nutr. Biochem. 2012
122
20

Butyrate improves insulin sensitivity and increases energy expenditure in mice.
Zhanguo Gao, Jun Yin, Jin Zhang, Robert E Ward, Roy J Martin, Michael Lefevre, William T Cefalu, Jianping Ye. Diabetes 2009
707
20

Metformin and the Gut Microbiome in Diabetes.
Sridevi Devaraj, Alamelu Venkatachalam, Xinpu Chen. Clin. Chem. 2016
3
33

Effects of LX4211, a dual SGLT1/SGLT2 inhibitor, plus sitagliptin on postprandial active GLP-1 and glycemic control in type 2 diabetes.
Brian Zambrowicz, Zhi-Ming Ding, Ike Ogbaa, Kenny Frazier, Phillip Banks, Anne Turnage, Joel Freiman, Melinda Smith, Dennis Ruff, Arthur Sands,[...]. Clin Ther 2013
50
20


Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study.
Nazarii Kobyliak, Ludovico Abenavoli, Tetyana Falalyeyeva, Galyna Mykhalchyshyn, Luigi Boccuto, Liudmyla Kononenko, Dmytro Kyriienko, Iuliia Komisarenko, Oleg Dynnyk. Minerva Med. 2018
26
20

Suppression of gut dysbiosis reverses Western diet-induced vascular dysfunction.
Micah L Battson, Dustin M Lee, Dillon K Jarrell, Shuofei Hou, Kayl E Ecton, Tiffany L Weir, Christopher L Gentile. Am. J. Physiol. Endocrinol. Metab. 2018
21
20

Microbiota and SCFA in lean and overweight healthy subjects.
Andreas Schwiertz, David Taras, Klaus Schäfer, Silvia Beijer, Nicolaas A Bos, Christiane Donus, Philip D Hardt. Obesity (Silver Spring) 2010
20


Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats.
Xu Zhang, Yufeng Zhao, Jia Xu, Zhengsheng Xue, Menghui Zhang, Xiaoyan Pang, Xiaojun Zhang, Liping Zhao. Sci Rep 2015
185
20

Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial.
Xiuying Zhang, Zhiwei Fang, Chunfang Zhang, Huihua Xia, Zhuye Jie, Xueyao Han, Yingli Chen, Linong Ji.  2017
36
20

Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases.
D Ortuño Sahagún, A L Márquez-Aguirre, S Quintero-Fabián, R I López-Roa, A E Rojas-Mayorquín.  2012
22
20

Beneficial effects of voglibose administration on body weight and lipid metabolism via gastrointestinal bile acid modification.
Hyun Ju Do, Youn Sue Lee, Min Jin Ha, Yoonsu Cho, Hana Yi, Yu-Jin Hwang, Geum-Sook Hwang, Min-Jeong Shin. Endocr. J. 2016
8
20

Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors.
A Amato, L Cinci, A Rotondo, R Serio, M S Faussone-Pellegrini, M G Vannucchi, F Mulè. Neurogastroenterol. Motil. 2010
62
20

Commensal gut bacteria modulate phosphorylation-dependent PPARγ transcriptional activity in human intestinal epithelial cells.
Malgorzata Nepelska, Tomas de Wouters, Elsa Jacouton, Fabienne Béguet-Crespel, Nicolas Lapaque, Joël Doré, Velmurugesan Arulampalam, Hervé M Blottière. Sci Rep 2017
23
20

Acarbose attenuates experimental non-alcoholic steatohepatitis.
Charles S Lieber, Maria A Leo, Ki M Mak, Youqing Xu, Qi Cao, Chaoling Ren, Anatoly Ponomarenko, Leonore M DeCarli. Biochem. Biophys. Res. Commun. 2004
21
20


The role of adipose tissue in mediating the beneficial effects of dietary fish oil.
Michael J Puglisi, Alyssa H Hasty, Viswanathan Saraswathi. J. Nutr. Biochem. 2011
69
20

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. Lancet 2002
20

Efficacy of Probiotics and Smectite in Rats with Non-Alcoholic Fatty Liver Disease.
Nazarii Kobyliak, Ludovico Abenavoli, Tetyana Falalyeyeva, Tetyana Beregova. Ann Hepatol 2018
6
20

GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.
Charles Pyke, R Scott Heller, Rikke K Kirk, Cathrine Ørskov, Steffen Reedtz-Runge, Peter Kaastrup, Anders Hvelplund, Linda Bardram, Dan Calatayud, Lotte Bjerre Knudsen. Endocrinology 2014
314
20

The Potential Role of the Dipeptidyl Peptidase-4-Like Activity From the Gut Microbiota on the Host Health.
Marta Olivares, Valentina Schüppel, Ahmed M Hassan, Martin Beaumont, Audrey M Neyrinck, Laure B Bindels, Alfonso Benítez-Páez, Yolanda Sanz, Dirk Haller, Peter Holzer,[...].  2018
14
20

Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
Nazarii Kobyliak, Tetyana Falalyeyeva, Oleksandr Virchenko, Galyna Mykhalchyshyn, Petro Bodnar, Mykola Spivak, Dmytro Yankovsky, Tetyana Beregova, Lyudmyla Ostapchenko. BMC Gastroenterol 2016
14
20

n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner.
Susanne Neschen, Katsutaro Morino, Jianying Dong, Yanlin Wang-Fischer, Gary W Cline, Anthony J Romanelli, Jörg C Rossbacher, Irene K Moore, Werner Regittnig, David S Munoz,[...]. Diabetes 2007
134
20

Altered circulating concentrations of active glucagon-like peptide (GLP-1) and dipeptidyl peptidase 4 (DPP4) in obese subjects and their association with insulin resistance.
Radwan H Ahmed, Hasniza Zaman Huri, Sekaran Muniandy, Zaid Al-Hamodi, Boshra Al-Absi, Abdulsamad Alsalahi, Muhammad Fm Razif. Clin. Biochem. 2017
12
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.